Leveraging a spectrum of cytogenomics methods for profiling complex karyotypes in chronic lymphocytic leukemia

A highly complex karyotype (high-CK) is a key biomarker of poor prognosis in chronic lymphocytic leukemia (CLL). While conventional methods lack the resolution to fully characterize complex structural variants (SVs), emerging technologies such as short-read WGS (sr-WGS), nanopore sequencing (ONT), optical genome mapping (OGM), and chromatin conformation capture (Micro-C) offer powerful tools for high-resolution SVs analysis, illuminating the genomic architecture underlying CLL. We selected nine CLL cases bearing diverse genomic alterations. Each underwent routine diagnostic evaluation via chromosome banding analysis (CBA), multicolor fluorescence in situ hybridization (mFISH), and chromosomal microarray (CMA) and was further analyzed using sr-WGS, ONT, OGM, and Micro-C. We performed a comprehensive comparison of copy number variants (CNVs) and SVs across all methods. Across five methods (CMA, ONT, OGM, sr-WGS, Micro-C), 56.3% (179/318) of CNVs were consistently detected. A high-confidence CNV set, defined as those identified by ≥ 3 methods, comprised 70.4% (224/318). SV detection varied by genome complexity: 2910 unique breakends (BNDs) were identified, with only 10.9% (320/2910) supported by all methods. A high-confidence SV set, supported by ≥ 3 methods, included 20.4% (595/2910) of BNDs. Dicentric chromosomes (DICs) and complex derivative chromosomes (CDERs), particularly those involving BNDs near centromeric or telomeric regions, were the most difficult to resolve. Micro-C fully confirmed 71.4% (5/7) of CDERs and all ten DICs. Overall, Micro-C aligned best with classical cytogenetics, confirming 85.5% (47/55) of aberrations, followed by OGM (65.5%) and both ONT and sr-WGS (56.4%). Each technology offers unique insights into the leukemia genome. Combining classical cytogenetics with high-throughput methods improves the detection of structural complexity and clinically relevant alterations.

Authors

Institutions

Publication Details

Journal
Human Genomics
Published
2026-04-11
DOI
https://doi.org/10.1186/s40246-026-00957-4
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Leveraging a spectrum of cytogenomics methods for profiling complex karyotypes in chronic lymphocytic leukemia

Kamila Stránská, Natálie Kazdová, Patricie Skaláková, Tobias Rausch et al.
Human Genomics
Chronic Lymphocytic Leukemia Research
article

Leveraging a spectrum of cytogenomics methods for profiling complex karyotypes in chronic lymphocytic leukemia

Kamila Stránská, Natálie Kazdová, Patricie Skaláková, Tobias Rausch, Kristýna Taušová, Vladimı́r Beneš, Eva Ondroušková, Jakub Paweł Porc, Jakub Hynšt, Jana Kotašková, Karla Plevová, Karol Pál, Marie Jarošová, Sarka Pospisilova, Sabina Penazova, Jan Svaton, Karolina Cernovska
article en

Abstract

A highly complex karyotype (high-CK) is a key biomarker of poor prognosis in chronic lymphocytic leukemia (CLL). While conventional methods lack the resolution to fully characterize complex structural variants (SVs), emerging technologies such as short-read WGS (sr-WGS), nanopore sequencing (ONT), optical genome mapping (OGM), and chromatin conformation capture (Micro-C) offer powerful tools for high-resolution SVs analysis, illuminating the genomic architecture underlying CLL. We selected nine CLL cases bearing diverse genomic alterations. Each underwent routine diagnostic evaluation via chromosome banding analysis (CBA), multicolor fluorescence in situ hybridization (mFISH), and chromosomal microarray (CMA) and was further analyzed using sr-WGS, ONT, OGM, and Micro-C. We performed a comprehensive comparison of copy number variants (CNVs) and SVs across all methods. Across five methods (CMA, ONT, OGM, sr-WGS, Micro-C), 56.3% (179/318) of CNVs were consistently detected. A high-confidence CNV set, defined as those identified by ≥ 3 methods, comprised 70.4% (224/318). SV detection varied by genome complexity: 2910 unique breakends (BNDs) were identified, with only 10.9% (320/2910) supported by all methods. A high-confidence SV set, supported by ≥ 3 methods, included 20.4% (595/2910) of BNDs. Dicentric chromosomes (DICs) and complex derivative chromosomes (CDERs), particularly those involving BNDs near centromeric or telomeric regions, were the most difficult to resolve. Micro-C fully confirmed 71.4% (5/7) of CDERs and all ten DICs. Overall, Micro-C aligned best with classical cytogenetics, confirming 85.5% (47/55) of aberrations, followed by OGM (65.5%) and both ONT and sr-WGS (56.4%). Each technology offers unique insights into the leukemia genome. Combining classical cytogenetics with high-throughput methods improves the detection of structural complexity and clinically relevant alterations.

Human Genomics
Central European Institute of Technology (CZ), Masaryk University (CZ), Central European Institute of Technology – Masaryk University (CZ), University Hospital Brno (CZ), European Molecular Biology Laboratory (DE)
No poverty
Openalex Percentile: Top 22%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.